Trial
NCT02358863
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
—
Condition
Esophageal Cancer
Intervention
Modified FOLFOX6
Why stopped
Issues with recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-06